AR090337A1 - PROCEDIMIENTO PARA OBTENER UNA COMPOSICION DE IgG MEDIANTE TRATAMIENTO TERMICO - Google Patents

PROCEDIMIENTO PARA OBTENER UNA COMPOSICION DE IgG MEDIANTE TRATAMIENTO TERMICO

Info

Publication number
AR090337A1
AR090337A1 ARP130100825A ARP130100825A AR090337A1 AR 090337 A1 AR090337 A1 AR 090337A1 AR P130100825 A ARP130100825 A AR P130100825A AR P130100825 A ARP130100825 A AR P130100825A AR 090337 A1 AR090337 A1 AR 090337A1
Authority
AR
Argentina
Prior art keywords
igg
procedure
composition
thermal treatment
polymers
Prior art date
Application number
ARP130100825A
Other languages
English (en)
Spanish (es)
Inventor
Ristol Debart Pere
Grancha Gamon Salvador
Original Assignee
Grifols Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=46053016&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR090337(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Grifols Sa filed Critical Grifols Sa
Publication of AR090337A1 publication Critical patent/AR090337A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39516—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum from serum, plasma
    • A61K39/39525—Purification
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39591—Stabilisation, fragmentation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/18—Ion-exchange chromatography
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/36—Extraction; Separation; Purification by a combination of two or more processes of different types
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065—Purification, fragmentation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Analytical Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Transplantation (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Confectionery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
ARP130100825A 2012-03-20 2013-03-14 PROCEDIMIENTO PARA OBTENER UNA COMPOSICION DE IgG MEDIANTE TRATAMIENTO TERMICO AR090337A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES201230413A ES2381828B1 (es) 2012-03-20 2012-03-20 PROCEDIMIENTO PARA OBTENER UNA COMPOSICION DE IgG MEDIANTE TRATAMIENTO TERMICO

Publications (1)

Publication Number Publication Date
AR090337A1 true AR090337A1 (es) 2014-11-05

Family

ID=46053016

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP130100825A AR090337A1 (es) 2012-03-20 2013-03-14 PROCEDIMIENTO PARA OBTENER UNA COMPOSICION DE IgG MEDIANTE TRATAMIENTO TERMICO

Country Status (21)

Country Link
US (1) US9200032B2 (https=)
EP (1) EP2641912B1 (https=)
JP (2) JP6048936B2 (https=)
KR (1) KR101840064B1 (https=)
CN (1) CN103319592B (https=)
AR (1) AR090337A1 (https=)
AU (1) AU2013201853B2 (https=)
BR (1) BR102013006411A2 (https=)
CA (1) CA2809513C (https=)
CL (1) CL2013000688A1 (https=)
ES (2) ES2381828B1 (https=)
HU (1) HUE027915T2 (https=)
IL (1) IL225197A (https=)
MX (1) MX339268B (https=)
MY (1) MY165024A (https=)
PL (1) PL2641912T3 (https=)
PT (1) PT2641912T (https=)
RU (1) RU2636049C2 (https=)
SG (1) SG193738A1 (https=)
TW (1) TWI554283B (https=)
UY (1) UY34679A (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2990033A1 (fr) * 2014-08-26 2016-03-02 Carlina Technologies Procédé de préparation de nanoprécipites de peptide ou protéine de faible poids moléculaire
TR201905974T4 (tr) * 2015-08-31 2019-05-21 Inst Grifols S A İmmünoglobuli̇nleri̇n hazirlanmasi i̇çi̇n yöntem
RU2708394C2 (ru) * 2016-09-26 2019-12-06 Институто Грифольс,С.А. Способ получения иммуноглобулинов
KR102791798B1 (ko) * 2018-04-12 2025-04-07 암젠 인크 안정한 단백질 조성물의 제조 방법
CN112557643B (zh) * 2019-09-26 2023-04-14 菲鹏生物股份有限公司 变性IgG和类风湿因子免疫抗原及制备方法
CN112858671B (zh) * 2019-11-27 2022-12-27 菲鹏生物股份有限公司 制备类风湿因子检测试剂的方法、类风湿因子检测试剂、试剂盒和检测方法

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US514375A (en) 1894-02-06 miller
CA1064396A (en) 1975-02-18 1979-10-16 Myer L. Coval Fractional precipitation of gamma globulin with polyethylene glycol
US4165370A (en) 1976-05-21 1979-08-21 Coval M L Injectable gamma globulin
EP0035204B2 (en) 1980-03-05 1991-05-22 Miles Inc. Pasteurized therapeutically active protein compositions
US4396608A (en) 1981-08-24 1983-08-02 Cutter Laboratories Intravenously injectable immune serum globulin
ES506679A0 (es) 1981-10-29 1982-08-16 Green Cross Corp Un procedimiento para preparar una immunoglobulina adecuada para inyeccion intravenosa
US4540573A (en) 1983-07-14 1985-09-10 New York Blood Center, Inc. Undenatured virus-free biologically active protein derivatives
JPH0825902B2 (ja) 1985-02-21 1996-03-13 株式会社ミドリ十字 γ−グロブリンの加熱処理方法
JPH0662436B2 (ja) 1986-05-19 1994-08-17 株式会社ミドリ十字 静注用免疫グロブリン製剤の製造方法
CA1310267C (en) 1986-07-09 1992-11-17 Yutaka Hirao Process for heat treating chemically unmodified _-globulin
JP2547556B2 (ja) 1987-02-06 1996-10-23 株式会社 ミドリ十字 ｒ−グロブリンの液状製剤
US4876241A (en) * 1987-05-22 1989-10-24 Armour Pharmaceutical Company Stabilization of biological and pharmaceutical products during thermal inactivation of viral and bacterial contaminants
ES2091161B1 (es) * 1995-04-12 1997-05-16 Grifols Grupo Sa Procedimiento para la produccion de gammaglobulina intramuscular inactivada por pasteurizacion.
AT403989B (de) * 1996-09-16 1998-07-27 Immuno Ag Verfahren zur herstellung eines plasmaprotein-hältigen arzneimittels
US5886154A (en) 1997-06-20 1999-03-23 Lebing; Wytold R. Chromatographic method for high yield purification and viral inactivation of antibodies
UA64742C2 (uk) * 1997-12-24 2004-03-15 Альфа Терапевтик Корпорейшн СПОСІБ ОДЕРЖАННЯ РОЗЧИНУ <font face="Symbol">g</font>-ГЛОБУЛІНУ, ПРИЗНАЧЕНОГО ДЛЯ ВНУТРІШНЬОВЕННОГО ВВЕДЕННЯ, І ПРОДУКТ, ЩО ОДЕРЖУЄТЬСЯ У ЦЕЙ СПОСІБ (ВАРІАНТИ)
NZ509135A (en) * 1998-06-09 2002-10-25 Statens Seruminstitut A third generation intravenous immunoglobulin G (IVIG) purified using column chromatographic ion exchange methods
DK2270044T3 (en) * 1998-06-09 2015-01-26 Csl Behring Ag Liquid immunoglobulin G (IgG) product
CN1137727C (zh) * 1998-06-25 2004-02-11 四川远大蜀阳药业有限公司 无保护剂双重病毒灭活制备静注免疫球蛋白工艺
ES2184594B1 (es) 2001-01-17 2004-01-01 Probitas Pharma Sa Procedimiento para la produccion de gammaglobulina g humana inactivada de virus.
DE602005021485D1 (de) * 2004-05-07 2010-07-08 Wisconsin Alumni Res Found Verfahren und zusammensetzungen mit molkeproteinisolaten
BRPI0812288A2 (pt) * 2007-06-01 2014-11-25 Hoffmann La Roche Purificação de imunoglobulina.
US8796430B2 (en) * 2010-05-26 2014-08-05 Baxter International Inc. Method to produce an immunoglobulin preparation with improved yield

Also Published As

Publication number Publication date
ES2590045T3 (es) 2016-11-17
KR101840064B1 (ko) 2018-03-19
UY34679A (es) 2013-10-31
US9200032B2 (en) 2015-12-01
MY165024A (en) 2018-02-28
AU2013201853A1 (en) 2013-10-10
SG193738A1 (en) 2013-10-30
PT2641912T (pt) 2016-08-12
CL2013000688A1 (es) 2014-02-28
US20140113355A1 (en) 2014-04-24
ES2381828A1 (es) 2012-06-01
ES2381828B1 (es) 2012-11-16
JP2013194054A (ja) 2013-09-30
RU2013112276A (ru) 2014-09-27
TW201343179A (zh) 2013-11-01
JP2016199586A (ja) 2016-12-01
BR102013006411A2 (pt) 2015-06-09
CA2809513A1 (en) 2013-09-20
KR20130106792A (ko) 2013-09-30
HK1185625A1 (en) 2014-02-21
MX339268B (es) 2016-05-18
MX2013002910A (es) 2013-09-19
JP6048936B2 (ja) 2016-12-21
IL225197A0 (en) 2013-06-27
PL2641912T3 (pl) 2016-11-30
TWI554283B (zh) 2016-10-21
CA2809513C (en) 2016-09-27
EP2641912A1 (en) 2013-09-25
CN103319592B (zh) 2020-03-03
AU2013201853B2 (en) 2014-07-03
HUE027915T2 (en) 2016-11-28
RU2636049C2 (ru) 2017-11-17
CN103319592A (zh) 2013-09-25
EP2641912B1 (en) 2016-06-15
IL225197A (en) 2017-06-29

Similar Documents

Publication Publication Date Title
AR090337A1 (es) PROCEDIMIENTO PARA OBTENER UNA COMPOSICION DE IgG MEDIANTE TRATAMIENTO TERMICO
Gross et al. Therapeutic strategies in fragile X syndrome: from bench to bedside and back
AR081427A1 (es) Metodo para preparar anticuerpos con propiedades mejoradas
EP2817439A4 (en) ALUMINUM ALLOY, ALUMINUM ALLOY RESIN COMPOSITE AND METHOD FOR THE PRODUCTION THEREOF
HUE048859T2 (hu) Gyûrûs bórsavészter származékok, eljárás elõállításukra, és terápiás alkalmazásuk
HUE036249T2 (hu) Szénszál-erõsítésû gyantakészítmény, eljárás szénszálerõsítésû gyantakészítmény elõállítására, formázóanyag, eljárás formázóanyag elõállítására és formázott, szénszál-erõsítésû gyanta termék
BR112012001481B8 (pt) Membranas de poli-imida, e seu processo de preparação
AR096113A1 (es) Polipéptidos f de prefusión del virus sincicial respiratorio (rsv) solubles y estabilizados
WO2013120012A3 (en) Cdim binding proteins and uses thereof
WO2015081085A3 (en) Methods of treating a tauopathy
BR112013032817A2 (pt) filmes e folhas de polipropileno
TR201908638T4 (tr) Ang2 bağlayıcı moleküller.
BR112015017806A2 (pt) processo para preparar produtos lácteos fermentados filtrados
EA201070046A1 (ru) Способ получения лекарственного средства, содержащего тадалафил
BR112015014158A2 (pt) poloxâmeros de cadeia prolongada, hidrogéis termor-reversíveis formados a partir dos mesmos com mate-riais biológicos e aplicações médicas dos mesmos
BR112015001185A2 (pt) reforço unidirecional e método para produzir um reforço unidirecional
EP2840418A4 (en) LIME LAMINATE, PROCESS FOR PREPARING A THIN POLARIZER, THEREFORE MADE THIN POLARIZER AND POLARIZATION PLATE THEREWITH
BR112015008907A2 (pt) processo e aparelho para produção de folha inorgânica
BR112016028635A2 (pt) artigo absorvente com adesivo isento de agente de pegajosidade
BR112013029416A2 (pt) derivados de indol substituídos para o tratamento de distúrbios imunológicos
UY31903A (es) 7-sulfanilmetil-,7-silfinilmetil-y7-sulfonilmetilindoles sustituidos y el uso de los mismos
BR112014014141A8 (pt) processo e dispositivo para a pasteurização e/ou esterilização de um alimento
CY1121260T1 (el) Μεθοδος για ληψη ενος διαπιδυσιμου εκχυλισματος λευκοκυτταρων
BR112015004276A2 (pt) fibra de polietileno de alto mfi, seu uso e processo para sua produção
CU20150019A7 (es) Rotavirus humanos modificados

Legal Events

Date Code Title Description
FB Suspension of granting procedure